72991-67-4

Upstream product

• 50563-68-3 1-(2,6-dimethylphenylamino)-propan-2-ol 
• 87-62-7 2,6-dimethylaniline 

Downstream Products

• 72992-26-8 N¹-(2,6-Dimethyl-phenyl)-N²-(3-trifluoromethyl-phenyl)-propane-1,2-diamine 
• 72992-06-4 N¹-(2,6-Dimethyl-phenyl)-N²-(2,4,6-trimethyl-phenyl)-propane-1,2-diamine 
• 83843-84-9 1-diisopropylamino-2-(2,6-dimethylphenyl-amino)-propane 
• 72991-94-7 3-(2,3-dimethyl-phenyl)-1-(2,6-dimethyl-phenyl)-4-methyl-imidazolidin-2-ylideneamine 
• 72992-17-7 1-(2,6-dimethyl-phenyl)-3-(4-methoxy-phenyl)-4-methyl-imidazolidin-2-ylideneamine 
• 72992-05-3 1-(2,6-dimethyl-phenyl)-4-methyl-3-(2,4,6-trimethyl-phenyl)-imidazolidin-2-ylideneamine 
• 83843-99-6 1-(2,6-dimethylphenyl-amino)-2-(2-diethylamino-acetamido)-propane 
• 83843-64-5 N²,N²-diethyl-N¹-(2,6-dimethyl-phenyl)-1-methyl-ethanediyldiamine 

Relevant academic research and scientific papers

New alkylene diamine derivatives

The invention is directed to 1-(2,6-Dimethyl-Phenyl-amino)-2-Dimethyl-amino-Propane and the pharmaceutical composition thereof useful for the treatment of cardiac rhythm disorders.

1,3-Diaryl-2-imino-imidazolidines and compositions thereof

The invention relates to new compounds of the general formula (I), STR1 wherein R1 and R5 each represent a phenyl group, optionally substituted, R2 stands for hydrogen, formyl group, carboxy group, lower alkoxycarbonyl gro